RxDoctor Payments Data

Alyssa Horowitz, MD

Obstetrics & Gynecology · Branchburg, NJNPI 1013943901

Payments from drug & device makers

$1,355in general payments, 2019–2025

Across 82 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Celularity Inc.$666
  • AbbVie$227
  • Mayne Pharma Commercial LLC$154
  • Pfizer$66
  • Roche Diagnostics Corporation$63
  • Therapeuticsmd, Inc.$52
  • plus $126 from 7 others

What the payments were for

  • Speaking & faculty fees$65048%
  • Food & beverage$70552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Celularity Inc.4$666
AbbVie(2 entities)42$227
Mayne Pharma Commercial LLC13$154
Pfizer4$66
Roche Diagnostics Corporation4$63
Therapeuticsmd, Inc.3$52
Exeltis, USA Inc.2$30
Organon1$25
Dysis Medical, Inc.1$22
Millicent US Inc1$18
Shield Therapeutics Inc1$17
Myovant Sciences Inc.1$14
Unified Women's Healthcare, LP5$0

How this compares

$1,355 in reported general payments places this provider in the 65th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$6,151
Medicare patients
37
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol14$1,239
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$163

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Branchburg

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →